𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PDB32 EVALUATING THE LONG-TERM CLINICAL AND ECONOMIC IMPLICATIONS OF CONVERTING TYPE 2 DIABETES PATIENTS TO INSULIN DETEMIR (±ORAL HYPOGLYCEMIC AGENTS) FROM INSULIN GLARGINE BASED REGIMENS IN GERMANY; DATA FROMTHE PREDICTIVE STUDY

✍ Scribed by WJ Valentine; G Goodall; M Aagren; S Nielsen; R Kotchie

Book ID
119595841
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
95 KB
Volume
10
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB54 COMPARISON OF TREATMENT COSTS BETW
PDB54 COMPARISON OF TREATMENT COSTS BETWEEN BASAL-SUPPORTED ORAL THERAPY (BOT) WITH INSULIN GLARGINE (GLA) AND BOT WITH INSULIN DETEMIR (DET) IN PATIENTS WITH TYPE 2 DIABETES (T2D): ECONOMIC EVALUATION BASED ON THE RESULTS OF THE INSULIN GLARGINE (LANTUS®) VERSUS INSULIN DETEMIR (LEVEMIR®) TREAT-TO-TARGET (L2T3) STUDY
✍ PK Schädlich; KC Koltermann; FW Dippel; EG Hagenmeyer; B Häussler 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB